Living donor liver transplantation for hepatocellular carcinoma.
about
Impact of non-oncological factors on tumor recurrence after liver transplantation in hepatocellular carcinoma patientsLiver transplantation for hepatocellular carcinoma from living-donor vs. deceased donorUpdate in management of hepatocellular carcinoma in Eastern population2014 KLCSG-NCC Korea Practice Guideline for the Management of Hepatocellular Carcinoma2014 Korean Liver Cancer Study Group-National Cancer Center Korea practice guideline for the management of hepatocellular carcinomaOutcomes of living and deceased donor liver transplant recipients with hepatocellular carcinoma: results of the A2ALL cohort.Hepatocellular carcinoma recurrence and death following living and deceased donor liver transplantation.Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma.Living Donor Liver Transplantation for Hepatocellular Carcinoma: It Is All about Donors?Hepatocellular carcinoma: early-stage management challengesExcellent outcome following down-staging of hepatocellular carcinoma prior to liver transplantation: an intention-to-treat analysis.Living-donor vs deceased-donor liver transplantation for patients with hepatocellular carcinoma.Effect of the pringle maneuver on tumor recurrence of hepatocellular carcinoma after curative resection (EPTRH): a randomized, prospective, controlled multicenter trial.Management of small hepatocellular carcinoma: a review of transplantation, resection, and ablation.The stratifying value of Hangzhou criteria in liver transplantation for hepatocellular carcinoma.Time to transplantation as a predictor of hepatocellular carcinoma recurrence after liver transplantation.Combined TACE and PEI for palliative treatment of unresectable hepatocellular carcinoma.Hepatocellular carcinoma: therapy and prevention.Smaller grafts do not imply early recurrence in recipients transplanted for hepatocellular carcinoma: A Chinese experienceManagement of hepatocellular carcinoma: Enlightening the gray zones.A pilot study of vasculogenic mimicry immunohistochemical expression in hepatocellular carcinoma.Tumor response to transcatheter arterial chemoembolization in recurrent hepatocellular carcinoma after living donor liver transplantation.Live donors in liver transplantation.Critical care of the end-stage liver disease patient awaiting liver transplantation.Should the liver transplant criteria for hepatocellular carcinoma be different for deceased donation and living donation?Is the treatment of hepatocellular carcinoma on the waiting list necessary?Recommendations for liver transplantation for hepatocellular carcinoma: an international consensus conference report.Is there an advantage of living over deceased donation in liver transplantation?The role of adult living donor liver transplantation and recent advances.Liver transplantation as a management of hepatocellular carcinoma.Recurrence of hepatocellular carcinoma after liver transplantation: an update.Pharmacokinetics of drugs in adult living donor liver transplant patients: regulatory factors and observations based on studies in animals and humans.Liver transplantation for hepatobiliary malignancies: a new era of "Transplant Oncology" has begun.Liver transplantation for hepatocellular carcinoma: outcomes and novel surgical approaches.Historical perspective of living donor liver transplantation.Contemporary strategies in the management of hepatocellular carcinomaA novel model measuring the harm of transplanting hepatocellular carcinoma exceeding Milan criteria.Living donor liver transplantation versus deceased donor liver transplantation for hepatocellular carcinoma: comparable survival and recurrence.Intention-to-treat analysis of liver transplantation for hepatocellular carcinoma: living versus deceased donor transplantation.Wait Time of Less Than 6 and Greater Than 18 Months Predicts Hepatocellular Carcinoma Recurrence After Liver Transplantation: Proposing a Wait Time "Sweet Spot".
P2860
Q26766049-60C70E16-1C24-4438-B527-B91984826A55Q28073940-7640E97D-8510-425E-985B-9E882657CAECQ28080480-B7407D2F-450C-4C9E-922A-5BE4D9F7FAC9Q28392783-3FBC7DDD-A1B2-4C09-84C2-DC735AE89DDFQ28394414-A66DD322-CC76-46FC-910B-C129DF1551BDQ30416480-0D397C86-79E2-4B43-98A3-50C00E582B29Q30430659-C2BB7862-C721-41A0-8B99-BC3749064FFFQ30479629-A9F86DD2-6258-4590-9DA7-587CDB9EA4FBQ33872038-05D99379-4B56-449C-B6DC-E2A60D00E32CQ33881131-9BB2E5D7-7E98-4B08-9250-6B110EAEADD0Q34080984-16BDA86A-A778-4FC2-BA79-7E3474EFF852Q34263346-B7F8A7DC-D915-45B9-8B6C-5892DA90F0C3Q34365785-554236B8-89BD-4ACD-B95A-218B3DD696BFQ35081063-89330A32-D0C2-442C-BC13-E61C36989483Q35133600-3681147C-63EB-415A-8FBC-F67772BE836AQ35384660-0D3BECA4-B0BF-408C-AD62-0C75DCCC942CQ35621307-22A33B91-82CB-4D60-B04C-8B46920094B8Q36377949-6D2A6D47-82E8-4B2E-9E6E-14A3766CE0D0Q36937325-8CA332BD-A733-44A4-A3C6-10C38AF3EDE2Q36955647-B6A5A48B-F6C4-4B9A-9DCA-FCF543FA7FD0Q37045531-2190760C-F40D-4ED5-B1D1-6C0B1533981FQ37062909-282998CE-47AC-4106-BAB9-8E539620EED9Q37124591-B0039892-3D53-4818-B749-E0716E138776Q37867071-BABA7CCF-1C4D-4E8D-80AB-4BA29CCA6773Q37883997-6C78E7A2-830C-4D8E-BC59-27A867D4A320Q37939790-41BCACDF-E320-4B73-A2F0-05B867B0ADF9Q37952030-70F79D24-CFA6-4833-BACC-9919435B8D52Q38039451-D5ED4C2D-6912-49BF-9E04-3C24F7FFDBD8Q38259414-14808A75-CAD5-4420-AC6B-86C92D523B14Q38519906-E3EBB1EF-DD2A-4950-BE12-32C373D8D381Q38594469-434CB367-7467-403F-B6BD-6865E9BB1C9FQ38711186-0F042B69-919F-487E-BB1A-2F28A0AFE24FQ38821374-E1013046-3577-4DF4-BE63-C057EBDB9695Q39067623-1BD26C40-966D-452A-AEE4-4E13E1BD90ECQ40136744-E983E244-ACF8-404A-8FAB-C6960D219FB6Q41659507-2414BA63-C285-4146-8CF7-343A0BFC207DQ44597163-1465B975-0406-440C-BBF2-41F6E8C31EEDQ44942457-D996D75F-C6D2-48E1-A056-E65522B6C9A0Q46082144-AE2CF25D-00F3-4CD8-B005-BA43B140815CQ46456307-CA0FA8B0-2494-4ABC-8E82-0F4F7871C8C9
P2860
Living donor liver transplantation for hepatocellular carcinoma.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Living donor liver transplantation for hepatocellular carcinoma.
@ast
Living donor liver transplantation for hepatocellular carcinoma.
@en
type
label
Living donor liver transplantation for hepatocellular carcinoma.
@ast
Living donor liver transplantation for hepatocellular carcinoma.
@en
prefLabel
Living donor liver transplantation for hepatocellular carcinoma.
@ast
Living donor liver transplantation for hepatocellular carcinoma.
@en
P1433
P1476
Living donor liver transplantation for hepatocellular carcinoma.
@en
P2093
Laura Kulik
Michael Abecassis
P304
P356
10.1053/J.GASTRO.2004.09.042
P407
P433
P577
2004-11-01T00:00:00Z